Scalds as a result of vapour inhalation therapy in children

Burns. 2008 Jun;34(4):560-4. doi: 10.1016/j.burns.2007.07.016. Epub 2007 Oct 22.

Abstract

Objective: To determine the numbers of paediatric scald injuries associated with the practice of inhaling warmed vapour or warm-humidification of rooms for treatment of upper respiratory tract infection (URTI).

Methods: Cases comprised a 6-year consecutive series of scalds in children 0-14 years attending the Royal Children's Hospital (RCH) in Brisbane, Australia. All scalds were sustained either directly from a container of hot water, or by room humidification.

Results: During 2001-2006, 27 children were treated for scald injury associated with breathing humidified air. Aged from 7 months to 14 years, 44% were under 3 years old and the modal age was 1 year. Injuries included steam burns to the hands from commercial vapour-producing devices in children younger than three, and spills from containers of hot water which resulted in larger scalds to multiple body sites in children aged 5-14. No child received an airway scald from hot vapour. Two children required grafts and four had a prolonged hospital stay. Total body surface area (TBSA) scalded, ranged from 1% to 15% and the majority of burns were deep dermal partial thickness.

Conclusions: The common practice of warm-humidification of inspired air as home treatment of URTI's carries an under-recognised risk of serious scalding. An alternative means of providing humidified air is to sit with your child in a closed bathroom whilst running the shower for a short time. If warm humidification is to be used, increased awareness of the risk by both parents and health professionals may reduce the incidence of this serious burn.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Burns / epidemiology
  • Burns / etiology*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Length of Stay
  • Male
  • Queensland / epidemiology
  • Respiratory Therapy / adverse effects*
  • Respiratory Tract Infections / therapy*
  • Seasons